Blog
Progress in Immune-Oncology Imaging
The advent of immune checkpoint inhibition and other immune-related therapies has produced a sea change in the treatment of a wide range of oncology indications. The impact of these new treatment [...]
April 22, 2019
Blog
As an attendee at the recent Global Nonalcoholic Steatohepatitis (NASH) Congress in London, England, I was among a good mix of academics and industry. Much of the conference focused on noninvasive [...]
March 15, 2019
Blog
February is American Heart Month
February 2019 marks the 55th anniversary of American Heart Month. Originally established by President Lyndon B. Johnson in December 1963, it marked a turning point in our collective approach to [...]
February 15, 2019
Blog
Response Assessment in Immune-Oncology
Seven years after the approval of the first immune checkpoint inhibitor for the treatment of metastatic melanoma, immunotherapy remains one of the primary areas of focus for oncology drug [...]
March 13, 2018
Blog
Ironically, the 2018 NASH-TAG conference in the Rocky Mountains featured much less snow than we have “enjoyed” in the northeast this winter. Weather forced one speaker to present remotely from his [...]
February 15, 2018
Blog
Archived Webinar: Body Composition in Clinical Trials – From BMI to MRI
According to the WHO, obesity is an epidemic that kills at least 2.8 million people each year. The number of obese children and adolescents worldwide has risen tenfold in the past four decades. [...]
January 16, 2018
